Occidental Asset Management’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-29,919
Closed -$496K 315
2025
Q4
$496K Buy
29,919
+247
+0.8% +$3.53K 0.06% 159
2025
Q3
$349K Hold
29,672
0.04% 189
2025
Q2
$285K Hold
29,672
0.04% 204
2025
Q1
$186K Hold
29,672
0.03% 239
2024
Q4
$241K Hold
29,672
0.04% 188
2024
Q3
$536K Hold
29,672
0.09% 139
2024
Q2
$306K Hold
29,672
0.05% 162
2024
Q1
$315K Hold
29,672
0.06% 155
2023
Q4
$271K Hold
29,672
0.06% 170
2023
Q3
$308K Hold
29,672
0.07% 161
2023
Q2
$425K Hold
29,672
0.1% 156
2023
Q1
$212K Hold
29,672
0.05% 187
2022
Q4
$333K Hold
29,672
0.09% 154
2022
Q3
$329K Hold
29,672
0.1% 140
2022
Q2
$250K Buy
+29,672
New +$305K 0.07% 156
2021
Q4
Sell
-12,872
Closed -$413K 215
2021
Q3
$413K Hold
12,872
0.11% 153
2021
Q2
$436K Hold
12,872
0.12% 151
2021
Q1
$483K Hold
12,872
0.14% 136
2020
Q4
$428K Buy
+12,872
New +$521K 0.14% 128

Other funds holding PHAT